A call for an open discussion of contradictory facts
Aids is defined by the existence of:
Under this, someone is declared to be suffering from Aids if they have had, for example, diarrhoea for more than a month, pronounced weight loss and coughing or general itching and no other cause can be ascertained with available means. On this definition an HIV test is not necessary, and shortage of funds means that a test is still only carried out occasionally today. And on the Ugandan health ministry's registration form for people with Aids the possibility of an HIV test is not even mentioned. Even the exclusion criteria will hardly prevent someone from beeing misdiagnosed of having Aids, as this definition was intended for poor countries. If they do not even have the possibility to perform an HIV-test it is hard to imagine how they should do any other diagnostic examination. (Based on this way of registering Aids cases Uganda was long considered the epicentre of the Aids epidemic.)
This means that Aids, the illness that in the words of Professor Luc Montagnier, the man who discovered HIV, "has no typical symptoms", is being diagnosed in developing countries exclusively on the basis of unspecific symptoms. (26) The symptoms called for are not exactly rare in a continent where, because of the many infectious illnesses and poor hygienic conditions, the average life expectancy is around 50 years. If a doctor in Europe formed his or her Aids diagnosis on such a basis they would probably have to face legal action and presumably be struck off the register.
On this issue, Dr Chin, the former Chief of the Forecasting and Impact Assessment unit at the Global Programme on Aids at the WHO, was writing as long ago as 1990: "It should be emphasised that surveillance definitions for Aids were not intended to be reliable indicators for HIV infection. Thus, in areas where the prevalence of HIV infection is very low, the WHO clinical definition primarily identifies patients with tuberculosis, severe malnutrition or diarrhoea." (27)
And even the US American Centers for Disease Control and the Pan-American Health Organisation arrived independently of each other at the conclusion that the WHO definition "may not be adequate for clinical work" because of "the potential inapplicability of that definition". They therefore established two further definitions for the diagnosis of Aids in developing countries. (28, 29)
It follows that the diagnosis of Aids in Africa has little to do with what is understood by this in Europe or the US. Rather, people who are suffering from well-known infectious diseases are now officially described as suffering from Aids. (30,31) This was tragically confirmed in the case of an Aids-infected child from Africa who was treated and re-nourished in Belgium. As a result the child no longer fulfilled the criteria of the African definition of Aids. (32)
Who is HIV positive in Africa ?
Fundamentally, all HIV tests do not identify the virus but particular antibodies in the blood. As always the controversy is over which antibodies are supposed to be typical for HIV and what methods can be used to determine this.
Interestingly, different antibodies are regarded as being typical for HIV in different countries and institutions. (33) The reliability of the various tests is also to some extent differently evaluated. Thus, for example, in England the Western Blot is not accepted in HIV diagnosis.
Regardless of this, however, some antibodies are very similar, so there is occasionally confusion. This means an HIV test wrongly gives a positive result when antibodies against a completely different pathogen are present. (This is essentially true for all such tests.) At the moment more than 70 illnesses or situations are recognised in which such positive results can occur, among others malaria, following blood transfusions, and leprosy. (34)
One study of the reliability of tests thus recommended that "the usual HIV tests (Elisa or Western Blot) are possibly not sufficient to diagnose infection with HIV in Central Africa." (35)
The current WHO estimates however, in particular for Africa, are based precisely on the results of these HIV tests on a small group of people. The spread of HIV in the rest of the population is then estimated on the basis of this data. The funds that the African countries should provide for preventative measures such as, for example, one billion US dollars as deemed necessary by UNAIDS are derived from just such an estimate of 23.3m people with HIV/Aids in Africa. (36, 37)
How are the figures interpreted?
All registered figures for Aids cases are collected at the WHO. These figures are added together even though they are based on totally different definitions. As the WHO writes in it's Bulletin: "Reports of AIDS cases from most of the industrialized countries of Europe, North America and Oceania are based primarily on the CDC/WHO definition; those from Africa are, in general, based on nationally adapted versions of the WHO clinical (Bangui) definition; and those from other countries involve a combination of these definitions." (27)
Finally, another figure is added on top of the registered cases in order to take account of the non-registered cases. Interestingly the number of registered cases in Africa has been relatively low in recent years. In contrast to this the estimate of non-registered cases has assumed unbelievable proportions. Thus the total number of Aids cases in Africa consists almost entirely not of registered cases but of cases estimated by he WHO.
|Cases in Africa (cumulative since 1980)||Reported
|Estimated underreporting in millions||Estimated total
|Estimated cases in % of the total|
|WHO report July 1994||0.33||2.35||2.68||88%|
|WHO report January 1995||0.35||2.8||3.15||89%|
|WHO report July 1996||0.5||5.43||5.93||91,6%|
|WHO report November 1997||0.62||9.78||10.4||94%|
|Cases between July 96 and November 97||0.12||4.4||4.5||97,3%|
Why should HIV be transmitted heterosexually in Africa?
As has already been mentioned, studies show that there is no independent spread of HIV/Aids in the heterosexual population in the US and Europe. The assumption that this should therefore happen in Africa and Thailand, for example, is not comprehensible. Further, it is without precedent in medicine that the transmission of a pathogen should be so different in different countries and continents.
The theory of the supposed heterosexual transmission of HIV in Africa and Thailand because of widespread promiscuity is based solely on the HIV tests described, which, as has been shown, often cannot be interpreted under tropical conditions. This belief among other things is contradicted by an international comparison of the number of sexual partners and sexual activity. Here the US leads, followed by France, Australia and Germany. In contrast, South Africa and Thailand are below the world average. (38)
It is logical to suppose that the widespread explanation has been so readily accepted because it fits in with the deep-rooted prejudices of the Christian countries concerning the sexuality of Africans (and Thailanders).
And if one reads the latest UNAIDS report the impression arises that HIV/Aids is being used as an apparently scientific proof of an enduring prejudice:
"Indeed, since not every encounter between an HIV-positive and an HIV-negative partner will result in a new infection, a sustain heterosexual epidemic suggests that a substantial proportion of the population, both male and female, have a number of sex partners over their lifetimes." (36)
This fixation on heterosexual transmission shows the extent to which the public discussion is shaped by Western convictions. In contrast, the dissemination of Western medicine as a possible cause for the spread of infectious diseases is played down. Yet it is generally well known that the extent of invasive techniques with injections, blood transfusions and operations, which characterises this form of medicine, can very quickly become dangerous if standards of hygiene are not observed. (39-41) And even the WHO confirms that "at minimum 12 billion injections are performed every year throughout the world", and "at least one third are not being carried out in a safe manner and may be spreading disease". The situation is particularly dramatic in Africa, where more than 80 per cent of disposable single-use syringes are used more than once." (42)
In contrast, traditional medicine is less successful, but also less dangerous when applied under poor hygiene conditions.
In view of the poverty in most African countries more than half of the population has no access to clean drinking water (43) the European fixation with a supposedly heterosexually transmitted Aids epidemic in Africa due to a promiscuous lifestyle can only be regarded as cynical.
What should be done?
Where is the information coming from?
This consideration is essential for an understanding of developments over the last 20 years, even if strictly speaking it does not have a medical aspect.
Most scientific information on HIV/Aids and advice on what to do about it comes from the US and to some extent from Europe or from organisations which operate from there. Developing countries are thereby particularly dependent on the industrialised countries when it comes to issues in their own country. Or, looked at from the other side, through the Aids discussion the industrialised countries have ensured themselves of a right to a say in the internal affairs of the developing countries, such as budget distribution and assessment of health priorities.
The international protest at the President of South Africa's initiative to raise critical questions has impressively demonstrated that developing countries are accorded no right to change this concept or to introduce their own considerations.
This monopolisation of information and control of the media facilitates manipulations that recall memories of colonial times.
People in Africa need our help and support. It is neither helpful nor effective if wrong data and absurd definitions are employed to mislead us and to divert attention from a country's real problems.
And most often these lie in well-known and treatable infectious diseases and are essentially caused by low standards of living.
Christian Fiala MD
Fax +43-1-597 31 92
1 Der Spiegel, Hamburg1994, no 32, page
148-50; also at http://www.uni-tuebingen.de/uni/tbi/kmw/t96pogf3.htm
2 Der Spiegel, Hamburg, 1985, no 39, page 85
3 Der Spiegel, Hamburg, 1990, no 26, page 193
4 Reason given by an Austrian Radio journalist for the cancellation of a planned interview with the author.
5 "Kumulative Verwirrung", Deutsches Ärzteblatt, 1989, 86, vol. 17, B 853/C 749
6 Krämer W., So lügt man mit Statistik, 1997, Frankfurt, Campus Verlag
7 European Centre for the epidemiological monitoring of Aids; HIV/AIDS Surveillance in Europe, 1998, Quarterly Report no 60, St. Maurice, France
8 "Todesursachen in Deutschland", Statistisches Bundesamt Wiesbaden, 1994
9 Centers for Disease Control (CDC), Update on acquired immune deficiency syndrome (Aids) - United States, MMWR, 1982, vol. 31, no 37; 507-14
10 CDC, "Revision of the case definition of Aids for national reporting - United States", MMWR, 1985, vol. 34; 373-5
11 CDC, "Revision of the CDC surveillance case definition for Aids", MMWR, 1987, vol. 36; 1-15 S
12 CDC, "1993 Revised classification system for HIV infection and expanded surveillance case definition for Aids among adolescents and adults", MMWR, 1992, December 18, vol. 41, no RR-17; 1-19
13 Steward; "Changing case-definition for AIDS", The Lancet, 1992, vol. 340, Dec 5; 1414
14 Ancelle-Park R et al.; "Impact of 1993 revision of adult/adolescent AIDS surveillance case definition for Europe", The Lancet, 1995; 345, 789-90
15 Selik-RM et al.; "Impact of the 1987 revision of the case definition of acquired immune deficiency syndrome in the United States", J-Acquir-Immune-Defic-Syndr, 1990; 3(1): 73-82
16 Vella-S et al.; "Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions", JAMA, 1994; Apr 20; 271(15): 1197-9
17 Stehr-Green-JK et al.; "Potential effect of revising the CDC surveillance case definition for AIDS", The Lancet, 1988; Mar. 5; 1(8584): 520-1
18 Smith-E et al.; Isager-H, "Impact of the 1987 revised AIDS case definition in Denmark: a follow-up study 2 years after its adoption", Scand-J-Infect-Dis, 1992; 24(3): 293-9
19 Cayla Joan et al; L'impact de la nouvelle definition de Sida à Barcelone, V. Int Conf Aids Montreal, 1989; Abstract T.A.O. 3
20 Pezzotti P et al.; "The effect of the 1993 European revision of the Aids case definition in Italy: implications for modeling the HIV epidemic", AIDS, 1997; 11: 95-9
21 1.7 CDC; Update: "Impact of the expanded Aids surveillance case definition for adolescents and adults on case reporting - United States", MMWR, 1994, March 11, vol. 43 no 9; 160-70
22 Robert Koch Institut, AIDS/HIV 1997, Berlin, 1999
23 Downs A et al., "Reconstruction and prediction of the HIV/Aids epidemic among adults in the European Union and in the low prevalence countries of central and eastern Europe", Aids, 1997; 11: 649-62
24 WHO; Workshop on Aids in Central Africa, Bangui 22-25 October 1985, Dokument WHO/CDS/AIDS/85.1, Geneva, 1985
25 WHO, "Global programme on AIDS; Provisional WHO clinical case definition for AIDS", Wkly-Epidemiol-Rec, 1986; March 7; no 10: 72-3
26 Luc Montagnier; "Des Virus et des Hommes, 1994", Editions Odile Jacob, Paris (German translation: Von Viren und Menschen, Rowohlt, 1997)
27 Chin J; "Public health surveillance of Aids and HIV infections", Bulletin of the WHO, 1990; 68(5): 529-36
28 De Cock et al.; "Aids surveillance in Africa: a reappraisal of case definitions", BMJ, 1991; 303: 1185-8
29 Weniger et al.; "A simplified surveillance case definition of AIDS derived from empirical clinical data", Journal Of Acquired Immune Deficiency Syndromes , 1992; 5: 1212-23
30 Gilks; "What use is a clinical case definition for AIDS in Africa?", BMJ, 1991; 303: 1189-90
31 Strecker-W et al.; "Epidemiology and clinical manifestation of HIV infection in northern Zaire", Eur-J-Epidemiol, 1994; Feb; 10(1): 95-8
32 Irova; "Aids-resembling disease in a non-HIV-infected African born to an HIV-positive mother", Pediatric Hematology and Oncology, 1995; 12: 495-8
33 Turner V; Perth, www.virusmyth.com/aids/data/vtwbtests.htm
34 Zenger's, 1996, published in Continuum, vol. 4, No 3, page 5
35 Kashala O. et al; Infection with HIV-1 and HTLV among leprosy patients and contacts: Correlation between HIV-1 cross-ractivity and antibodies to lipoarabinomannan, J Infect Dis , 1994; 169: 296-304
36 UNAIDS, AIDS epidemic update: December 1999, Geneva www.unaids.org/
37 UNAIDS, HIV/AIDS in Africa - Socio-economic impact and response, Conference 6-8 May 1999, Addis Ababa, www.unaids.org/
38 Durex, Global Sex Survey, London, 1997, http://www.durex.com
39 Salehe O. et al.; The amount of HIV-infections caused by syringes and needles in Mbeya-region, Second National Seminar on Aids Research in Tanzania, Dar es Salaam 1994
40 Wyatt HV. et al., "Unnecessary injections and paralytic poliomyelitis in India", Transactions of the Royal Society of Tropical Medicine, 1992; 86: 546-9
41 Wyatt HV et al., "Unnecessary injections in developing countries: the risk and costs", International Journal of Risk & Safety in Medicine, 1993; 4: 167-76
42 WHO, GPV declares war on unsafe injections, Geneva, The newsletter of the Global Programme for Vaccines and Immunization, 5, 1997, GPV/VIN/97.03
43 WHO Water supply an sanitation sector monitoring report 1996, Geneva WHO/EOS/96.15
44 Deutsche Latex Forschung, Kondom-Absatz in Deutschland, Düsseldorf
45 Statistisches Jahrbuch 1996, Statistisches Bundesamt Wiesbaden
|RETOUR À CRITIQUES||HOME PAGE||CONTACTS||NOS PUBLICATIONS||COMMANDES et DONATIONS|